Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G for Aethlon Medical, Inc. Common Stock, $0.001 par value per share (AEMD).
- Disclosed ownership: 8.7%.
- Date of event: 31 Dec 2024.
Ikarian Capital, LLC - 31 Dec 2024 SCHEDULE 13G Report for Aethlon Medical, Inc. Common Stock, $0.001 par value per share (AEMD)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- AEMD
- Shares outstanding
- 14,129,713 shares
- Disclosed Ownership
- 1,229,285 shares
- Ownership
- 8.7%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 13:21:10 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 8.7% ownership in Aethlon Medical, Inc. Common Stock, $0.001 par value per share (AEMD) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 13:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 8.7% | 1,229,285 | 0 | 1,229,285 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 8.7% | 1,229,285 | 0 | 1,229,285 | /s/Neil Shahrestani | Neil Shahrestani |